美国 · SEC FORM 4
LABCORP HOLDINGS INC.
LH · NYSE · CIK 0000920148 · Healthcare · Diagnostics & Research
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
14 同一窗口内观察到的 Form 4 交易行
9 sales · 5 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
—
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2022-09-07 · Caveney Brian J.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 2,684,363
- 上期报告
- 2,448,617
- 日均成交量
- 892,507
- 回补天数
- 3.0
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2022-09-07 | Caveney Brian J | 买入 (P) | Common Stock | 44 | USD 231.20 | USD 10,251 | SEC 申报 ↗ |
| 2022-06-07 | Caveney Brian J | 买入 (P) | Common Stock | 42 | USD 242.19 | USD 10,174 | SEC 申报 ↗ |
| 2022-02-16 | NEUPERT PETER M | 买入 (P) | Common Stock | 3,500 | USD 263.66 | USD 922,815 | SEC 申报 ↗ |
| 2020-03-10 | Seltz Judith C | 买入 (P) | Common Stock | 330 | USD 168.56 | USD 55,625 | SEC 申报 ↗ |
| 2020-02-28 | Seltz Judith C | 买入 (P) | Common Stock | 250 | USD 174.94 | USD 43,735 | SEC 申报 ↗ |
Form 4 申报证据
150 transaction lines in the latest 365-day window; 872 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-08-17 | ANDERSON KERRII B | 卖出 (S) | Common Stock | 3,000 | USD 318.02 | USD 954,060 | SEC 申报 ↗ |
| 2026-08-11 | Schechter Adam H | 卖出 (S) | Common Stock | 4,669 | USD 320.37 | USD 1,495,808 | SEC 申报 ↗ |
| 2026-08-04 | Summy Amy B. | 卖出 (S) | Common Stock | 924 | USD 306.74 | USD 283,428 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-08-17 | ANDERSON KERRII B | 卖出 (S) | Common Stock | 3,000 | USD 318.02 | USD 954,060 | SEC 申报 ↗ |
| 2026-08-11 | Schechter Adam H | 卖出 (S) | Common Stock | 4,669 | USD 320.37 | USD 1,495,808 | SEC 申报 ↗ |
| 2026-08-04 | Summy Amy B. | 卖出 (S) | Common Stock | 924 | USD 306.74 | USD 283,428 | SEC 申报 ↗ |
| 2026-08-03 | Wilkinson Peter J | 卖出 (S) | Common Stock | 1,420 | USD 309.23 | USD 439,106 | SEC 申报 ↗ |
| 2026-08-03 | Wilkinson Peter J | 期权行权／转换 (M) | Common Stock | 1,338 | USD 209.25 | USD 279,976 | SEC 申报 ↗ |
| 2026-07-02 | Vaughn Bryan T | 卖出 (S) | Common Stock | 234 | USD 286.19 | USD 66,968 | SEC 申报 ↗ |
| 2026-07-02 | Kyle Kathryn W | 卖出 (S) | Common Stock | 92 | USD 286.19 | USD 26,329 | SEC 申报 ↗ |
| 2026-07-01 | Vaughn Bryan T | 期权行权／转换 (M) | Common Stock | 327 | USD — | USD — | SEC 申报 ↗ |
| 2026-07-01 | Vaughn Bryan T | 代扣税 (F) | Common Stock | 93 | USD 283.88 | USD 26,401 | SEC 申报 ↗ |
| 2026-07-01 | Kyle Kathryn W | 期权行权／转换 (M) | Common Stock | 256 | USD — | USD — | SEC 申报 ↗ |
| 2026-07-01 | Kyle Kathryn W | 代扣税 (F) | Common Stock | 73 | USD 283.88 | USD 20,723 | SEC 申报 ↗ |
| 2026-06-08 | Kyle Kathryn W | 卖出 (S) | Common Stock | 762 | USD 263.89 | USD 201,084 | SEC 申报 ↗ |
| 2026-05-11 | Schechter Adam H | 卖出 (S) | Common Stock | 5,903 | USD 254.50 | USD 1,502,314 | SEC 申报 ↗ |
| 2026-03-27 | Wilkinson Peter J | 卖出 (S) | Common Stock | 1,633 | USD 267.05 | USD 436,093 | SEC 申报 ↗ |
| 2026-03-27 | Meltzer Jonathan C | 卖出 (S) | Common Stock | 839 | USD 267.05 | USD 224,055 | SEC 申报 ↗ |
| 2026-03-26 | van der Vaart Sandra D | 代扣税 (F) | Common Stock | 2,722 | USD 268.38 | USD 730,530 | SEC 申报 ↗ |
| 2026-03-26 | van der Vaart Sandra D | 奖励／授予 (A) | Common Stock | 6,382 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-26 | Wilkinson Peter J | 代扣税 (F) | Common Stock | 755 | USD 268.38 | USD 202,627 | SEC 申报 ↗ |
| 2026-03-26 | Wilkinson Peter J | 奖励／授予 (A) | Common Stock | 2,388 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-26 | Vaughn Bryan T | 代扣税 (F) | Common Stock | 451 | USD 268.38 | USD 121,039 | SEC 申报 ↗ |
| 2026-03-26 | Vaughn Bryan T | 奖励／授予 (A) | Common Stock | 1,584 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-26 | Summy Amy B. | 代扣税 (F) | Common Stock | 1,836 | USD 268.38 | USD 492,746 | SEC 申报 ↗ |
| 2026-03-26 | Summy Amy B. | 奖励／授予 (A) | Common Stock | 3,994 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-26 | Schroeder Mark S | 代扣税 (F) | Common Stock | 6,068 | USD 268.38 | USD 1,628,530 | SEC 申报 ↗ |
| 2026-03-26 | Schroeder Mark S | 奖励／授予 (A) | Common Stock | 12,272 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-26 | Schechter Adam H | 代扣税 (F) | Common Stock | 26,106 | USD 268.38 | USD 7,006,328 | SEC 申报 ↗ |
| 2026-03-26 | Schechter Adam H | 奖励／授予 (A) | Common Stock | 58,470 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-26 | Oyegunwa Akinbolade | 代扣税 (F) | Common Stock | 382 | USD 268.38 | USD 102,521 | SEC 申报 ↗ |
| 2026-03-26 | Oyegunwa Akinbolade | 奖励／授予 (A) | Common Stock | 1,340 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-26 | Meltzer Jonathan C | 代扣税 (F) | Common Stock | 711 | USD 268.38 | USD 190,818 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | LH |
| CIK | 0000920148 |
| 行业 | Healthcare |
| 细分行业 | Diagnostics & Research Yahoo Finance |
| SEC SIC | 8071 Services-Medical Laboratories |
| 交易所 | NYSE |
数据覆盖
| 本地 Form 4 历史 | 872 transaction lines from 2020-02-07 to 2026-08-17 7 P purchase lines · 141 S sale lines · 724 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.